Next Article in Journal
Marine Bioactive Compounds Derived from Macroalgae as New Potential Players in Drug Delivery Systems: A Review
Next Article in Special Issue
Characterization of Novel Bacteriophage vB_KpnP_ZX1 and Its Depolymerases with Therapeutic Potential for K57 Klebsiella pneumoniae Infection
Previous Article in Journal
Lactoferrin Decreases Enterotoxigenic Escherichia coli-Induced Fluid Secretion and Bacterial Adhesion in the Porcine Small Intestine
Previous Article in Special Issue
Genomic and Functional Characterization of Vancomycin-Resistant Enterococci-Specific Bacteriophages in the Galleria mellonella Wax Moth Larvae Model
 
 
Article
Peer-Review Record

In Vitro Evaluation of Five Newly Isolated Bacteriophages against E. faecalis Biofilm for Their Potential Use against Post-Treatment Apical Periodontitis

Pharmaceutics 2022, 14(9), 1779; https://doi.org/10.3390/pharmaceutics14091779
by Marie Voit 1,2, Andrej Trampuz 1,2 and Mercedes Gonzalez Moreno 1,2,*
Reviewer 2: Anonymous
Pharmaceutics 2022, 14(9), 1779; https://doi.org/10.3390/pharmaceutics14091779
Submission received: 26 July 2022 / Revised: 22 August 2022 / Accepted: 22 August 2022 / Published: 25 August 2022

Round 1

Reviewer 1 Report

In the article "In vitro evaluation of five newly isolated bacteriophages against E. faecalis biofilm for their potential use against post-treatment apical periodontitis", the authors characterize the properties of five new phages including their host range and bacteriacidal capacity. The experiments are well thought out, and compelling. I have a few points I would like to see clarified prior to publication. 

1. Host range experiments demonstrated that most of the phages are capable of infecting a range of E. faecalis strains. Further experiments showed use of only one host strain with its similarly named phage. Would you please include a brief description in the results or discussion section as to why these particular pairings were chosen rather than attempting to examine the properties of each phage across all of its potential hosts?

2. Similarly, in the section looking at the antibiotic resistant strain EF04, please explain why use of CUB_EF14 was not also examined.

3. While the experimental design for 3.6 "Assessment of bacterial resistance to development to phage" was described in the materials and methods, it is not clear in the text of the results section that exposure to CUB_EF03, CUB_EF06, CUB_EF10, and CUB_EF14 is following a previous exposure to either strain's paired phage. As this is essential to the significance of the results presented in Figure 6, it would be nice to have this clarified here as well. 

Author Response

Please see the attachement

Author Response File: Author Response.docx

Reviewer 2 Report

Dear Authors, 

I read the manuscript with interest. I think the research is well planned and carried out, and the manuscript is well written. I just have a few comments:

1. You reported that five different phages were isolated (CUB-EF03, CUB-04, CUB-EF06, CUB-EF10, CUB-EF14, but in the subsection 3.3. Time-Killing Assay results were described only for four phages (CUB-EF03, CUB-FE06, CUB-10, CUB-14). It should be explained why only these four phages are selected for the assay. 

2. Similar to the above, the Assessment of bacterial resistance development to phage (subsection 3.6.) does not present results for CUB_EF04. Please, explain this. 

In the 3.6 subsection, the results are described for CUB-EF10, CUB-EF14, CUB-EF03, and CUB-EF06. In the corresponding subsection 2.9 Assessement of Bacterial Resistance Development to Phage in the Results paragraph, only CUB-EF10 and CUB-EF14 are mentioned. Why?

Author Response

Please see the attachement

Author Response File: Author Response.docx

Back to TopTop